Patients with SLE-AAV overlap syndrome are mostly female, commonly present with rapidly progressive glomerulonephritis (RPGN), and have both antinuclear antibodies (ANA) and anti-myeloperoxidase (anti-MPO) antibodies. This evidence concerns the gene MPO and rapidly progressive glomerulonephritis.